News Sentiment

ARVN sentiment intelligence

Arvinas Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 51 Balanced news tone 62 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 8.27 Week of 10 Jul 2026
Weighted tone 51/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

78/100 classification confidence.

Company focus 53

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

-1.4% over one week, +9.1% over four weeks, trend inactive, and below fair value.

Latest direct headline Negative

Trading the Move, Not the Narrative: (ARVN) Edition

Market Reaction

Balanced read

58/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 78/100 classification
One-week reaction -1.4% Price digesting
Trend fit Trend inactive 9.1% over four weeks
Fair value -57.9% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 9
Neutral 48
Negative 5

Relevance

Why the article matched

Direct first
Direct company coverage 53
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 19
Market source 10
simplywall.st 5
TradingView 3
TradingKey 3
Investing.com 3
GlobeNewswire 3
Investing.com Nigeria 2

Event Lens

What the news is about

Classified themes
Market update 31
Earnings 17
Deals and strategy 5
Analyst action 4
Regulatory and legal 2
Capital return 1
Guidance 1
Balance sheet 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 62
Stock Traders Daily Direct company coverage

Trading the Move, Not the Narrative: (ARVN) Edition

This article analyzes Arvinas Inc. (NASDAQ: ARVN) using AI models to provide trading strategies based on different risk profiles and holding periods. It highlights weak near-term sentiment but long-term strength, with specific entry, target, and stop-loss levels for position trad

Tone
Negative 38/100
Event
Analyst action
Published
17 Jul 2026 05:34
Source
Stock Traders Daily
Stock Titan Direct company coverage

Morgan Stanley (ARVN) broker files Form 144 to sell 24,000 shares

Morgan Stanley Smith Barney LLC has filed a Form 144 notice indicating its intent to sell 24,000 shares of common stock in Arvinas, Inc. (ARVN). These sales are tied to restricted stock vesting under a registered plan, with specific vesting lots scheduled for March 2025, February

Tone
Neutral 50/100
Event
Market update
Published
09 Jul 2026 20:41
Source
Stock Titan
Finviz Direct company coverage

ARVN - Arvinas Inc Latest SEC Filings

This article provides a detailed financial overview and recent SEC filing information for Arvinas Inc. (ARVN). It covers various financial metrics including market capitalization, sales, income, profitability ratios, insider and institutional ownership, stock performance, and ana

Tone
Neutral 50/100
Event
Market update
Published
03 Jul 2026 10:10
Source
Finviz
Stock Titan Direct company coverage

Arvinas (ARVN) director receives RSU and stock option grants in equity award

Arvinas (ARVN) director Leslie V. Norwalk received routine equity compensation through a grant of 15,527 restricted stock units (RSUs) and an option to purchase 22,714 shares of common stock at $8.05 per share. These awards, granted on June 24, 2026, are not open-market trades an

Tone
Neutral 50/100
Event
Market update
Published
27 Jun 2026 08:10
Source
Stock Titan
Investing.com South Africa Direct company coverage

Form 4 Arvinas Inc For: 26 June By Investing.com

This article from Investing.com reports the filing of a Form 4 for Arvinas Inc. on June 26. The content includes market data for various indices, currencies, and commodities, reflecting market performance. It also lists trending stocks and popular articles related to financial ne

Tone
Neutral 50/100
Event
Market update
Published
26 Jun 2026 22:26
Source
Investing.com South Africa
Stock Titan Direct company coverage

Arvinas (ARVN) director Briggs Morrison granted RSUs and stock options

Arvinas (ARVN) director Briggs Morrison was granted 15,527 restricted stock units (RSUs) and 22,714 stock options with an exercise price of $8.05 per share. These equity awards, reported on a Form 4 filing, are subject to vesting criteria tied to continued service and the company

Tone
Neutral 50/100
Event
Market update
Published
26 Jun 2026 20:41
Source
Stock Titan
Stock Titan Direct company coverage

Director Linda Bain receives RSUs and stock options at Arvinas (ARVN)

Arvinas, Inc. director Linda Bain was granted 15,527 restricted stock units (RSUs) and stock options for 22,714 shares at an exercise price of $8.05 per share. Both the RSUs and options vest fully on the earlier of June 24, 2027, or immediately before the first annual stockholder

Tone
Neutral 50/100
Event
Market update
Published
26 Jun 2026 20:41
Source
Stock Titan
Stock Titan Direct company coverage

[Form 4] ARVINAS, INC. Insider Trading Activity

Edward M. Kennedy Jr., a director at ARVINAS, INC. (ARVN), received new equity awards comprising 15,527 restricted stock units (RSUs) and an option to purchase 22,714 shares at an exercise price of $8.05 per share. These awards were granted on June 24, 2026, and are set to vest f

Tone
Neutral 50/100
Event
Market update
Published
26 Jun 2026 20:41
Source
Stock Titan
Stock Titan Direct company coverage

Arvinas (ARVN) director receives new RSU and stock option awards

Arvinas, Inc. director Everett Cunningham was granted 15,527 restricted stock units (RSUs) and a stock option for 22,714 shares at an exercise price of $8.05, according to a June 24, 2026 filing. Both awards are set to vest on the earlier of June 24, 2027, or immediately before t

Tone
Neutral 50/100
Event
Market update
Published
26 Jun 2026 20:37
Source
Stock Titan
TradingView Direct company coverage

Arvinas, Inc. Actuals & Estimates (NASDAQ:ARVN)

This article provides key financial actuals and estimates for Arvinas, Inc. (NASDAQ:ARVN), including its current stock price, market capitalization, historical highs and lows, and analyst forecasts. It also details recent earnings, revenue, net income, and upcoming earnings repor

Tone
Neutral 50/100
Event
Earnings
Published
26 Jun 2026 06:41
Source
TradingView
TradingKey Direct company coverage

Arvinas Inc (ARVN) Institutional Confidence

Arvinas Inc (ARVN) has an institutional shareholding score of 7.00, placing it 80th out of 387 in the Biotechnology & Medical Research industry. The institutional shareholding proportion is 83.59%, which is a decrease of 50.35% quarter-over-quarter. Bill Nygren | OAKMX is the lar

Tone
Negative 39/100
Event
Market update
Published
26 Jun 2026 04:40
Source
TradingKey
Stock Titan Direct company coverage

Arvinas (NASDAQ: ARVN) investors back directors, pay and auditor

Arvinas, Inc. held its annual meeting on June 24, 2026, where stockholders elected Leslie V. Norwalk, Esq. and Randy Teel, Ph.D. as Class II directors. They also approved, on a non-binding advisory basis, the compensation for named executive officers and ratified Deloitte & Touch

Tone
Neutral 50/100
Event
Market update
Published
25 Jun 2026 20:40
Source
Stock Titan
Investing.com Direct company coverage

Arvinas CFO Andrew Saik sells $46,473 in company stock

Arvinas CFO Andrew Saik sold 5,696 shares of company stock for $46,473 to cover tax withholding obligations related to the vesting of restricted stock units. This was not a discretionary trade. The stock is currently trading below its fair value, despite a recent earnings report

Tone
Negative 40/100
Event
Earnings
Published
25 Jun 2026 20:09
Source
Investing.com
Investing.com Nigeria Direct company coverage

Form 4 Arvinas Inc For: 24 June By Investing.com

This article from Investing.com reports on a Form 4 filing for Arvinas Inc (ARVN) dated June 24, 2026. Form 4s disclose transactions by company insiders, but the article provides no specific details about the transactions, only listing the filing and referencing the stock ticker.

Tone
Neutral 50/100
Event
Market update
Published
25 Jun 2026 19:37
Source
Investing.com Nigeria
TradingView Direct company coverage

ARVN Forecast — Price Target — Prediction for 2027

This article provides a forecast for Arvinas, Inc. (ARVN) stock, including analyst price targets, current stock performance, and financial data. It highlights that the stock has a price target of 15.07 USD based on 14 analysts, with a max estimate of 24.00 USD and a min of 6.00 U

Tone
Neutral 50/100
Event
Analyst action
Published
25 Jun 2026 18:40
Source
TradingView
Stock Titan Direct company coverage

ARVINAS (ARVN) CFO auto-sells shares to cover RSU tax withholding

ARVINAS, INC.'s Chief Financial Officer, Andrew Saik, automatically sold 5,696 shares of common stock at $8.159 per share to cover tax withholding obligations related to the vesting of his restricted stock units. This was a non-discretionary sale made by the company and not a per

Tone
Neutral 50/100
Event
Market update
Published
24 Jun 2026 21:10
Source
Stock Titan
Investing.com Nigeria Direct company coverage

Form 144 Arvinas Inc For: 23 June By Investing.com

This article from Investing.com reports on Form 144 for Arvinas Inc. filed on June 23rd. Form 144 is a notice of the intent to sell restricted securities. The brief article provides no further details beyond the filing date and company name.

Tone
Neutral 50/100
Event
Market update
Published
24 Jun 2026 18:11
Source
Investing.com Nigeria
TradingView Direct company coverage

ARVN: All voting items passed at the virtual meeting, with no shareholder questions submitted

Arvinas, Inc. (ARVN) held its virtual Annual General Meeting (AGM) where all proposed agenda items were approved by shareholders. These items included director elections, executive compensation, and auditor ratification. No shareholder questions were submitted during the meeting.

Tone
Positive 62/100
Event
Market update
Published
24 Jun 2026 13:41
Source
TradingView
Stock Titan Direct company coverage

Arvinas (NASDAQ: ARVN) to settle 5,846 vested RSU shares on 06/24/2026

Arvinas, Inc. (NASDAQ: ARVN) is set to settle 5,846 shares of common stock stemming from vested restricted stock units on June 24, 2026, through Morgan Stanley Smith Barney LLC. The SEC Form 144 filing also notes a previous disposition of 11,139 shares by Andrew Saik on May 11, 2

Tone
Neutral 50/100
Event
Market update
Published
23 Jun 2026 21:40
Source
Stock Titan
Stock Titan Direct company coverage

[8-K] ARVINAS, INC. Reports Material Event

ARVINAS, INC. has reported a material event in an 8-K filing, announcing that Chief Medical Officer Noah Berkowitz, M.D., Ph.D. will depart from the company on July 3, 2026. A separation agreement includes nine months of base salary, health premiums, and accelerated vesting of ce

Tone
Neutral 50/100
Event
Market update
Published
23 Jun 2026 05:40
Source
Stock Titan
MarketBeat Direct company coverage

Arvinas, Inc. $ARVN Stock Holdings Lifted by Armistice Capital LLC

Armistice Capital LLC significantly increased its stake in Arvinas, Inc. (NASDAQ:ARVN) by 50% in the fourth quarter, now holding 1.8 million shares valued at $21.35 million. While institutional investors are increasing positions, company insiders, including the CFO, recently sold

Tone
Neutral 50/100
Event
Earnings
Published
19 Jun 2026 22:09
Source
MarketBeat
Stock Titan Direct company coverage

Arvinas (ARVN) CSO has shares sold automatically to cover RSU tax withholding

Arvinas, Inc.'s Chief Scientific Officer, Angela M. Cacace, automatically sold 2,576 shares of common stock at $7.595 per share. This non-discretionary sale was executed by the issuer to cover tax withholding obligations arising from the vesting of restricted stock units (RSUs).

Tone
Neutral 50/100
Event
Market update
Published
18 Jun 2026 19:43
Source
Stock Titan
The Globe and Mail Direct company coverage

Rigel Deal for VEPPANU Cleared, Arvinas Receives Payment

Rigel Pharmaceuticals has secured exclusive global rights to develop and commercialize VEPPANU from Arvinas and Pfizer, following the early termination of the Hart-Scott-Rodino waiting period. This agreement triggered an upfront payment of $70 million, shared by Arvinas and Pfize

Tone
Positive 64/100
Event
Deals and strategy
Published
18 Jun 2026 05:40
Source
The Globe and Mail
TradingKey Direct company coverage

Arvinas Inc (ARVN) Earnings Forecast: Future EPS & Revenue Growth Estimates

Arvinas Inc (ARVN) has an earnings forecast score of 7.40, ranking 293 out of 388 in the Biotechnology & Medical Research industry. The average analyst price target for ARVN is $14.00, with 18 analysts predominantly recommending a "Buy" trend. The company's expected revenue for t

Tone
Positive 76/100
Event
Earnings
Published
17 Jun 2026 23:09
Source
TradingKey
TradingKey Direct company coverage

Arvinas Inc (ARVN) Dividends & Stock Splits: Historical Payouts and Event Timeline

The article provides a historical overview of Arvinas Inc's (ARVN) dividend payouts and stock splits, noting that the company has distributed $0.00 in dividends over the past five years. It also indicates that there is no historical data available for stock splits. The content pr

Tone
Neutral 50/100
Event
Capital return
Published
17 Jun 2026 21:10
Source
TradingKey